Emergent BioSolutions
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$1.79B N/A	$1.12B -37.47%	$1.04B -6.38%	Avg: $1.13B Low: $1.13B High: $1.13B avg. 8.45%	Avg: $1.14B Low: $1.14B High: $1.14B avg. 0.47%	Avg: $904.5M Low: $904.5M High: $904.5M avg. -20.89%
Net Income % change YoY	$219.5M N/A	$-223.8M -201.95%	$-760.5M -239.81%	Avg: $-58.88M Low: $-58.88M High: $-58.88M avg. 92.25%	Avg: $-62.44M Low: $-62.44M High: $-62.44M avg. -6.06%	Avg: $-51.71M Low: $-51.71M High: $-51.71M avg. 17.19%
EBITDA % change YoY	$514.4M N/A	$-34.4M -106.68%	$-505.29M -1368.89%	Avg: $176.54M Low: $176.54M High: $176.54M avg. 134.93%	Avg: $177.37M Low: $177.37M High: $177.37M avg. 0.47%	Avg: $140.32M Low: $140.32M High: $140.32M avg. -20.89%
EPS % change YoY	$4.1 N/A	-$4.47 -209.02%	-$14.85 -232.21%	Avg: -$1.15 Low: -$1.15 High: -$1.15 avg. 92.25%	Avg: -$1.22 Low: -$1.22 High: -$1.22 avg. -6.06%	Avg: -$1.01 Low: -$1.01 High: -$1.01 avg. 17.19%
Operating Expenses % change YoY	$640.9M N/A	$593.2M -7.44%	$1.04B 75.99%	Avg: $291.36M Low: $291.36M High: $291.36M avg. -72.09%	Avg: $292.73M Low: $292.73M High: $292.73M avg. 0.47%	Avg: $231.58M Low: $231.58M High: $231.58M avg. -20.89%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 34.46% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is -58.88M, average is -58.88M and high is -58.88M.

Wall Street analysts forecast annual average revenue growth of -3.98% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $1.13B, average is $1.13B and high is $1.13B.

Wall Street analysts forecast annual average earnings growth of 34.46% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.15, average is -$1.15 and high is $-1.15.